During the inflammatory response that drives atherogenesis, macrophages accumulate progressively in the expanding arterial wall 1,2 . The observation that circulating monocytes give rise to lesional macrophages 3-9 has reinforced the concept that monocyte infiltration dictates macrophage buildup. Recent work has indicated, however, that macrophage accumulation does not depend on monocyte recruitment in some inflammatory contexts 10 . We therefore revisited the mechanism underlying macrophage accumulation in atherosclerosis. In murine atherosclerotic lesions, we found that macrophages turn over rapidly, after 4 weeks. Replenishment of macrophages in these experimental atheromata depends predominantly on local macrophage proliferation rather than monocyte influx. The microenvironment orchestrates macrophage proliferation through the involvement of scavenger receptor A (SR-A). Our study reveals macrophage proliferation as a key event in atherosclerosis and identifies macrophage self-renewal as a therapeutic target for cardiovascular disease.
During the inflammatory response that drives atherogenesis, macrophages accumulate progressively in the expanding arterial wall 1, 2 . The observation that circulating monocytes give rise to lesional macrophages [3] [4] [5] [6] [7] [8] [9] has reinforced the concept that monocyte infiltration dictates macrophage buildup. Recent work has indicated, however, that macrophage accumulation does not depend on monocyte recruitment in some inflammatory contexts 10 . We therefore revisited the mechanism underlying macrophage accumulation in atherosclerosis. In murine atherosclerotic lesions, we found that macrophages turn over rapidly, after 4 weeks. Replenishment of macrophages in these experimental atheromata depends predominantly on local macrophage proliferation rather than monocyte influx. The microenvironment orchestrates macrophage proliferation through the involvement of scavenger receptor A (SR-A). Our study reveals macrophage proliferation as a key event in atherosclerosis and identifies macrophage self-renewal as a therapeutic target for cardiovascular disease.
Over the last 30 years, macrophages have emerged as protagonists of atherosclerosis and its complications. Macrophages amass in lesions, ingest lipids and produce a diverse repertoire of inflammatory mediators that exacerbate disease 1, 2 . In mice, lesional macrophages arise predominantly from circulating Ly-6C high monocytes [5] [6] [7] [11] [12] [13] . These insights have contributed to the perception that macrophages gradually accrue in atherosclerotic lesions in which a single infiltrating monocyte yields one terminally differentiated macrophage. Recent observations that monocyte kinetics in acute injury are rapid 14 , that tissue macrophages may not depend on monocytes 10, 15 and that the adventitia harbors hematopoietic progenitors 16 suggest potential alternative explanations for how atherosclerosis evolves. The prevailing models, therefore, require re-evaluation. Do lesional macrophages in atherosclerosis accumulate gradually or turn over rapidly? To answer this question, we subcutaneously implanted osmotic pumps containing the thymidine analog BrdU in 4-month-old apolipoprotein E-deficient (Apoe −/− ) mice consuming a high-cholesterol diet (HCD) for 8 weeks. BrdU incorporates into newly synthesized DNA and thus reports on the cell's proliferative history. Nearly all (92% ± 1% (mean ± s.e.m.)) of aortic macrophages, identified as Lin − CD11b + CD11c −/low F4/80 high cells by flow cytometry ( Fig. 1a) , stained for BrdU after 4 weeks (when the mice were 5 months old) ( Fig. 1b,c) . Immunofluorescence experiments identified Mac3 + BrdU + macrophages within plaque intima and adventitia ( Fig. 1d-f) . This low-level BrdU administration had no intrinsic effect on macrophage turnover kinetics because the rate of BrdU signal decay after pump removal closely approximated its rate of incorporation ( Fig. 1c) . Despite an increase in lesion size over the BrdU labeling period ( Fig. 1g) , aortic root macrophage burden did not change significantly ( Fig. 1h ), suggesting that at this stage of atherosclerosis, cell loss processes counterbalance macrophage renewal. These data identify a previously unrecognized dynamic in the mononuclear phagocytic response during atherosclerosis and reveal rapid macrophage turnover in lesions.
Lesional macrophages could replenish through either continuous recruitment of circulating monocytes or some other process. We assessed aortic macrophage accumulation in Apoe −/− HCD-fed mice depleted of circulating monocytes for 5 d (Fig. 2a) . Monocyte depletion had no effect on BrdU incorporation by aortic macrophages (Fig. 2b,c) , the total number of aortic macrophages ( Fig. 2d ) or total lesion area ( Supplementary Fig. 1a ). To examine the relationship between blood monocytes and tissue macrophages in more detail, we joined 4-month-old CD45.1 + Apoe −/− HCD-fed and CD45.2 + Apoe −/− HCD-fed mice (8 weeks of HCD) for 5 weeks by parabiosis, a procedure that allows circulating cells to enter partner tissues 17 . This procedure did not alter the frequency of monocytes in the blood Local proliferation dominates lesional macrophage accumulation in atherosclerosis l e t t e r s nature medicine VOLUME 19 | NUMBER 9 | SEPTEMBER 2013 1 1 6 7 Fig. 1b ) and had no effect on BrdU incorporation in aortic macrophages ( Supplementary Fig. 1c ). Whereas Ly-6C high monocyte chimerism in the blood (30% ± 5% (mean ± s.e.m.)), spleen (26% ± 4%) and aorta (25% ± 6%) were high-and typical of monocyte chimerism at equilibrium 18 -macrophage chimerism in the aorta was low (5% ± 2%) ( Fig. 2e-g) . This discrepancy between monocyte and macrophage chimerism, observed here in the setting of established disease, illustrates either slow macrophage replenishment or macrophage replenishment that does not rely exclusively on monocyte influx. Because macrophages replenish rapidly in established atherosclerosis (~4 weeks; Fig. 1 ), macrophage accumulation probably occurs through processes other than monocyte infiltration. Surgical separation of parabionts provided complementary evidence in support of this conclusion. Separation led to a decline in monocyte chimerism in the blood, spleen and aorta, but the chimerism of lesional macrophages remained unchanged for at least 2 weeks after separation ( Fig. 2h ). Together these data show that monocyte recruitment cannot fully account for lesional macrophage accumulation in established atherosclerosis. Macrophage turnover that is largely independent of monocytes does not preclude the initial development of plaque macrophages from hematopoietic precursors. Convergence of monocyte and macrophage chimerism in a parabiosis setting can be interpreted as partial evidence that tissue macrophages derive from circulating monocytes.
(Supplementary
To determine if and when monocyte and macrophage chimerism converges, we joined relatively young (during early atherosclerosis, 8 weeks old, no HCD before parabiosis) mice in parabiosis for 4 weeks. Unlike in established disease ( Fig. 2e-g) , blood monocyte and aortic macrophage chimerism in these mice was similar ( Supplementary  Fig. 2a ), which is consistent with previous observations that early development of atherosclerotic lesions depends on monocyte recruitment 19 . To determine whether circulating cells eventually repopulate aortic macrophages in established disease, we lethally irradiated and reconstituted 4-month-old CD45.2 + Apoe −/− HCD-fed mice with bone marrow from CD45.1 + Apoe −/− mice. Over the course of 5 months, aortic macrophages in these mice were replenished by donor-derived CD45.1 + cells (Supplementary Fig. 2b ). These data suggest that even though rapid lesional macrophage turnover does not require constant monocyte influx, aortic macrophages ultimately derive from a circulating precursor.
The recent identification of hematopoietic progenitors in the aortic adventitia 16 raises the possibility that lesional macrophages arise from circulating intima-seeded multipotent hematopoietic stem and progenitor cells (HSPCs). To address this possibility, we performed granulocyte-macrophage colony-forming experiments on aortic tissue. As shown previously 11 , HSPCs were highly active in the bone marrow and spleens of Apoe −/− HCD-fed mice (Fig. 3a) . Conversely, the entire aorta yielded no more than two macrophage colonies per mouse ( Fig. 3a) . These data are consistent with a recent study on HSPC activity in the vascular wall 16 and indicate that local hematopoiesis of a multiproliferative adventitial progenitor contributes minimally to lesional macrophage accumulation in atherosclerosis. npg Macrophage proliferation in atherosclerotic lesions has been identified in humans, rabbits and mice [20] [21] [22] [23] [24] [25] [26] , but its importance relative to monocyte recruitment has not been evaluated. We investigated this issue using several independent and complementary approaches. First, we adoptively transferred Ly-6C high monocytes from GFP + mice to Apoe −/− mice consuming an HCD. Twenty-four hours after transfer, we injected BrdU to track proliferation. Two days after this BrdU pulse, we detected nonproliferating BrdU − GFP + monocytes in the recipient blood ( Fig. 3b) . In the aorta, GFP + cells were located in either the F4/80 low BrdU − cell population, representing a few monocytes that had accumulated but had neither differentiated nor proliferated, or the F4/80 high cell population, representing monocyte-derived macrophages, some of which had proliferated locally (BrdU + ) ( Fig. 3b) .
These data indicate that proliferating aortic macrophages derive from nonproliferating circulating monocytes. Future studies will be needed to determine whether lesion-infiltrating monocytes, in addition to differentiating, die locally or exit. Second, we performed a 2-h in vivo BrdU pulse-labeling experiment, which has been used previously to detect neointimal dendritic cell proliferation 19 . At a time point when circulating monocytes had not yet incorporated BrdU (Supplementary Fig. 3a) , aortic macrophages in both Apoe −/− ( Fig. 3c ) and low-density lipoprotein receptor-deficient (Ldlr −/− ) ( Supplementary Fig. 3b ) mice were already BrdU + , indicating local proliferation. Third, analysis of the S and G 2 /M phases of the cell cycle using the intercalating dye DAPI revealed a high percentage of proliferating aortic macrophages in 4-month-old Apoe −/− mice consuming an HCD (Fig. 3d) . This finding contrasted with findings in 4-month-old wild-type (WT) or young (2-month-old) chow-fed Apoe −/− mice in which there was a lower level of aortic macrophage proliferation ( Fig. 3e) . Monocytes did not proliferate in any of these groups of mice ( Fig. 3b,d) . Fourth, positive staining of gated G 2 /M-phase aortic macrophages for phosphorylated histone H3 (pH3) confirmed mitosis in 4-month-old Apoe −/− HCD-fed mice (Fig. 3f) . Fifth, to directly visualize cell division, we used the ImageStreamX Mark II platform, which is a technique that links multiparameter flow cytometry with singlecell immunofluorescence imaging. Analysis of 4-month-old Apoe −/− HCD-fed mice showed G 2 /M-phase aortic macrophages in various phases of mitosis ( Fig. 3g) . Sixth, immunofluorescence of aortic root sections from 4-month-old Apoe −/− HCD-fed mice showed numerous intimal Mac3 + macrophages staining positive for nuclear proliferation antigen Ki67 (Fig. 3h) . The key to interpreting the results of these last four experiments is the ability of DAPI, pH3 and Ki67 to identify currently, rather than formerly, proliferating cells. The colocalization of markers of cell division with mature macrophage markers (F4/80 by flow cytometry and Mac3 by immunofluorescence) indicates that aortic macrophages proliferate. Immunohistochemistry of atherosclerotic plaques from human carotid arteries revealed Ki67-expressing Oil Red O + and CD68 + lesional macrophages ( Supplementary  Fig. 3c ), indicating that in situ proliferation of mature intimal macrophages also occurs in human atherosclerosis. Although classic studies have shown that the dominant proliferative cell type in the human intima is the macrophage in both early 23 and advanced atherosclerosis 21, 22 , it remains to be determined whether local macrophage proliferation contributes substantially to human lesion growth, turnover and rupture.
To quantify the contribution of local proliferation to macrophage accumulation in established atherosclerotic lesions, we joined 4-month-old CD45.1 + Apoe −/− HCD-fed and CD45.2 + Apoe −/− HCDfed (8 weeks on the HCD) mice by parabiosis and implanted them with BrdU-containing osmotic pumps for 4 weeks (Fig. 3i) . This experiment allowed us to assess macrophage chimerism exclusively in newly accumulating BrdU + macrophages. Among newly accumulating macrophages in CD45.1 + mouse aortas, only 4% were CD45.2 + (Fig. 3i) , which agrees with our previous observations ( Fig. 2e,f) argues against macrophage residential longevity as the determining factor for low chimerism. Aortic chimerism alone underestimates the overall contribution of circulating monocytes because monocyte chimerism in the blood, even at equilibrium, is only ~30% (Fig. 3i) . Therefore, assuming that individual CD45.1 + and CD45.2 + cells can infiltrate lesions equally, for every partner-derived (CD45.2 + ) monocyte that entered the CD45.1 + aorta, approximately two endogenous (CD45.1 + ) monocytes also entered. Hence, the total contribution of the circulation (CD45.1 + and CD45.2 + ) to macrophage accumulation in a 4-week period in established disease can be at most ~13% (Fig. 3j) . Local proliferation, which accounts for the remaining ~87% of newly labeled BrdU + macrophages, dominates macrophage accumulation in established atherosclerosis (Fig. 3j) . Similar studies conducted during early atherosclerosis, when the lesional macrophage burden is still minimal (Supplementary Fig. 2a) , demonstrated a larger contribution of recruited monocytes to macrophage accumulation (Fig. 3j) . Collectively these data show that as atherosclerosis progresses, macrophage turnover becomes increasingly dependent on local proliferation of lesional macrophages. Because lesional macrophages reside in a tissue context, macrophage proliferation might depend on the local microenvironment. We addressed this possibility using several approaches. First, we joined 4-month-old WT (CD45.1 + ) and Apoe −/− (CD45.2 + ) HCD-fed mice by parabiosis. The joined partners consumed an HCD for 5 weeks. During this period, atherosclerotic lesions persisted in the Apoe −/− partner but did not develop in the WT partners, as assessed by gross examination (data not shown). Aortic macrophage chimerism was low in both mice (Fig. 4a) npg or WT), macrophages accumulating in the Apoe −/− partner were more likely to proliferate compared to macrophages accumulating in the WT partner (Fig. 4a,b) . We also assessed macrophage proliferation in Apoe −/− HCD-fed mice in different aortic segments of the same mouse. Proliferation was highest among macrophages located in the aortic root and arch (where lesions are most abundant), was intermediate among macrophages located in the thoracic aorta (intermediate abundance) and was lowest in the abdominal aorta (least abundance) ( Supplementary Fig. 4) . To discriminate between lesional and adventitial macrophage proliferation, we separated the intima from the vessel wall as previously described 27 . Whereas adventitial macrophages in 6-month-old Ldlr −/− HCD mice (16 weeks of HCD) proliferated at a rate similar to that observed in young nonatherosclerotic mice, lesional macrophages proliferated at a high rate (Fig. 4c) . Thus, the microenvironment influences macrophage proliferation.
By what mechanism do lesional macrophages proliferate? Somewhat surprisingly given the known role of granulocyte-macrophage colony-stimulating factor (GM-CSF) in myeloid cell differentiation and neointimal dendritic cell proliferation 19 , neither neutralizing antibodies nor genetic manipulation targeting this growth factor or its receptor, respectively, affected macrophage proliferation ( Supplementary  Fig. 5a,b) . We turned our attention to the type 1 scavenger receptor class A (SR-A, also known as Msr1), which is expressed on lesional macrophages 28, 29 , recognizes modified low-density lipoproteins 30 and whose expression correlates with macrophage proliferation 31 . We generated mixed chimeric mice by irradiating and reconstituting 8 week-old Ldlr −/− mice with a mixture of WT CD45.1 + and Msr1 −/− CD45.2 + bone marrow cells (Fig. 4d) . This approach allowed us to compare the proliferation of Msr1-competent and -deficient macrophages in the same lesional microenvironment. Two weeks after bone marrow transplantation, the mice were placed on an HCD for an additional 16 weeks. At this time, we detected moderately fewer bone marrow and circulating Msr1 −/− CD45.2 + compared to WT CD45.1 + monocytes (Supplementary Fig. 5c ). In the aorta, we observed ~60% fewer Msr1 −/− CD45.2 + macrophages compared to WT CD45.1 + cells (Supplementary Fig. 5d ). After mice were pulsed with BrdU for 2 h, circulating monocytes were almost entirely BrdU − regardless of genotype ( Fig. 4e) . Compared to WT cells, Msr1 −/− macrophages proliferated less (Fig. 4f) , and BrdU + Msr1 −/− macrophages were far less abundant in lesions (Fig. 4g) . These data indicate that Msr1 contributes to the life cycle of proliferating macrophages in established atherosclerosis. Future work will be needed to elucidate whether the effect is direct or indirect and to investigate the mechanistic links between Msr1-mediated apoptosis, endoplasmic reticulum stress and proliferation 31, 32 .
The finding that local macrophage proliferation contributes substantially to lesional macrophage accumulation prompted us to test whether interference with cell proliferation can reduce established atherosclerosis. We administered Apoe −/− HCD-fed mice the cellcycle inhibitor fluorouracil (5-FU). It is known that 5-FU decreases the production of monocytes 33 . However, we delivered the drug for only 4 weeks, a period of time in which we showed that monocytes contribute little to macrophage accumulation in established atherosclerosis. 5 l e t t e r s nature medicine VOLUME 19 | NUMBER 9 | SEPTEMBER 2013 1 1 7 1 Supplementary Fig. 6a ) and number (P < 0.05; Supplementary  Fig. 6b ) of proliferating aortic macrophages. The overall effect of 5-FU administration was fewer Mac3 + macrophages and smaller lesions (P < 0.05; Supplementary Fig. 6c-e ). These data are consistent with studies in which genetic disruption of tumor-suppressor genes and cell-cycle regulators promotes macrophage proliferation and increases atherosclerosis 34, 35 . These findings demonstrate that cellular proliferation is a dominant feature of atherosclerotic development and a promising therapeutic target. Atherosclerosis is a lipid-driven inflammatory disease that is characterized by monocyte recruitment and differentiation 1 . When lesions regress, monocyte recruitment is suppressed 13 . Our study builds on this paradigm by providing evidence that in addition to monocyte recruitment and differentiation, monocyte-derived lesional macrophages proliferate. Our data indicate that atherosclerosis develops through a multiphasic numerical escalation of the monocyte-macrophage lineage. Its sequence can be summarized as follows: first, hematopoietic stem cells proliferate in the bone marrow and spleen and give rise to monocytes 11, 36, 37 ; second, monocytes circulate, infiltrate and differentiate into macrophages [5] [6] [7] 13 ; and third, lesional macrophages proliferate and locally augment their numbers in plaques (Fig. 4h) . The concept that substantial local expansion of mononuclear phagocytes results from cell proliferation within the intimal lesion adds a new dimension to our understanding of lesional leukokinetics. Moving forward, it will be essential to evaluate the importance of local macrophage proliferation in human atherosclerosis and to determine how interfering with monocyte recruitment and macrophage proliferation at various stages of atherosclerosis affects plaque progression.
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